Logo image of HRI

HERC HOLDINGS INC (HRI) Stock Fundamental Analysis

USA - NYSE:HRI - US42704L1044 - Common Stock

131.202 USD
+1.83 (+1.42%)
Last: 10/22/2025, 12:24:05 PM
Fundamental Rating

4

Overall HRI gets a fundamental rating of 4 out of 10. We evaluated HRI against 49 industry peers in the Trading Companies & Distributors industry. HRI has a medium profitability rating, but doesn't score so well on its financial health evaluation. HRI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year HRI was profitable.
In the past year HRI had a positive cash flow from operations.
HRI had positive earnings in each of the past 5 years.
Each year in the past 5 years HRI had a positive operating cash flow.
HRI Yearly Net Income VS EBIT VS OCF VS FCFHRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

HRI has a worse Return On Assets (0.16%) than 65.31% of its industry peers.
The Return On Equity of HRI (1.20%) is worse than 63.27% of its industry peers.
With a Return On Invested Capital value of 4.17%, HRI perfoms like the industry average, outperforming 40.82% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HRI is below the industry average of 10.04%.
Industry RankSector Rank
ROA 0.16%
ROE 1.2%
ROIC 4.17%
ROA(3y)4.38%
ROA(5y)4.04%
ROE(3y)24.04%
ROE(5y)21%
ROIC(3y)7.69%
ROIC(5y)7%
HRI Yearly ROA, ROE, ROICHRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

HRI's Profit Margin of 0.61% is on the low side compared to the rest of the industry. HRI is outperformed by 63.27% of its industry peers.
HRI's Profit Margin has improved in the last couple of years.
HRI has a better Operating Margin (19.40%) than 79.59% of its industry peers.
HRI's Operating Margin has improved in the last couple of years.
HRI has a Gross Margin of 59.67%. This is amongst the best in the industry. HRI outperforms 91.84% of its industry peers.
In the last couple of years the Gross Margin of HRI has grown nicely.
Industry RankSector Rank
OM 19.4%
PM (TTM) 0.61%
GM 59.67%
OM growth 3Y4.56%
OM growth 5Y10.96%
PM growth 3Y-18.21%
PM growth 5Y20%
GM growth 3Y1.25%
GM growth 5Y3.11%
HRI Yearly Profit, Operating, Gross MarginsHRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. Health

2.1 Basic Checks

HRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HRI has more shares outstanding
HRI has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, HRI has an improved debt to assets ratio.
HRI Yearly Shares OutstandingHRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
HRI Yearly Total Debt VS Total AssetsHRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

HRI has an Altman-Z score of 0.72. This is a bad value and indicates that HRI is not financially healthy and even has some risk of bankruptcy.
HRI has a worse Altman-Z score (0.72) than 87.76% of its industry peers.
A Debt/Equity ratio of 4.37 is on the high side and indicates that HRI has dependencies on debt financing.
HRI's Debt to Equity ratio of 4.37 is on the low side compared to the rest of the industry. HRI is outperformed by 87.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.37
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACC0.46
WACC9.07%
HRI Yearly LT Debt VS Equity VS FCFHRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

HRI has a Current Ratio of 1.15. This is a normal value and indicates that HRI is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.15, HRI is not doing good in the industry: 83.67% of the companies in the same industry are doing better.
HRI has a Quick Ratio of 1.15. This is a normal value and indicates that HRI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.15, HRI is in line with its industry, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
HRI Yearly Current Assets VS Current LiabilitesHRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The earnings per share for HRI have decreased by -9.02% in the last year.
HRI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 48.42% yearly.
Looking at the last year, HRI shows a quite strong growth in Revenue. The Revenue has grown by 11.41% in the last year.
Measured over the past years, HRI shows a quite strong growth in Revenue. The Revenue has been growing by 12.29% on average per year.
EPS 1Y (TTM)-9.02%
EPS 3Y19.73%
EPS 5Y48.42%
EPS Q2Q%-28.08%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y19.84%
Revenue growth 5Y12.29%
Sales Q2Q%18.16%

3.2 Future

Based on estimates for the next years, HRI will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.12% on average per year.
Based on estimates for the next years, HRI will show a quite strong growth in Revenue. The Revenue will grow by 14.16% on average per year.
EPS Next Y-34.22%
EPS Next 2Y-8%
EPS Next 3Y2.01%
EPS Next 5Y12.12%
Revenue Next Year25.3%
Revenue Next 2Y19.56%
Revenue Next 3Y15.88%
Revenue Next 5Y14.16%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HRI Yearly Revenue VS EstimatesHRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B
HRI Yearly EPS VS EstimatesHRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15 20

5

4. Valuation

4.1 Price/Earnings Ratio

HRI is valuated reasonably with a Price/Earnings ratio of 11.82.
HRI's Price/Earnings ratio is rather cheap when compared to the industry. HRI is cheaper than 87.76% of the companies in the same industry.
HRI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.77.
A Price/Forward Earnings ratio of 12.02 indicates a correct valuation of HRI.
Based on the Price/Forward Earnings ratio, HRI is valued cheaper than 85.71% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.23, HRI is valued a bit cheaper.
Industry RankSector Rank
PE 11.82
Fwd PE 12.02
HRI Price Earnings VS Forward Price EarningsHRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

81.63% of the companies in the same industry are more expensive than HRI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.89
HRI Per share dataHRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.24
EPS Next 2Y-8%
EPS Next 3Y2.01%

3

5. Dividend

5.1 Amount

HRI has a Yearly Dividend Yield of 2.16%.
Compared to an average industry Dividend Yield of 1.81, HRI pays a better dividend. On top of this HRI pays more dividend than 89.80% of the companies listed in the same industry.
HRI's Dividend Yield is comparable with the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 2.16%

5.2 History

HRI has been paying a dividend for over 5 years, so it has already some track record.
HRI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
HRI Yearly Dividends per shareHRI Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

HRI pays out 343.48% of its income as dividend. This is not a sustainable payout ratio.
DP343.48%
EPS Next 2Y-8%
EPS Next 3Y2.01%
HRI Yearly Income VS Free CF VS DividendHRI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
HRI Dividend Payout.HRI Dividend Payout, showing the Payout Ratio.HRI Dividend Payout.PayoutRetained Earnings

HERC HOLDINGS INC

NYSE:HRI (10/22/2025, 12:24:05 PM)

131.202

+1.83 (+1.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners102.39%
Inst Owner Change0.04%
Ins Owners2.01%
Ins Owner Change0.8%
Market Cap4.36B
Revenue(TTM)3.78B
Net Income(TTM)23.00M
Analysts75.38
Price Target153.58 (17.06%)
Short Float %7.41%
Short Ratio4.68
Dividend
Industry RankSector Rank
Dividend Yield 2.16%
Yearly Dividend2.72
Dividend Growth(5Y)N/A
DP343.48%
Div Incr Years3
Div Non Decr Years3
Ex-Date08-22 2025-08-22 (0.7)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.6%
Min EPS beat(2)-42.15%
Max EPS beat(2)20.95%
EPS beat(4)1
Avg EPS beat(4)-8.78%
Min EPS beat(4)-42.15%
Max EPS beat(4)20.95%
EPS beat(8)2
Avg EPS beat(8)-6.25%
EPS beat(12)3
Avg EPS beat(12)-5.38%
EPS beat(16)4
Avg EPS beat(16)-4.53%
Revenue beat(2)2
Avg Revenue beat(2)0.73%
Min Revenue beat(2)0.38%
Max Revenue beat(2)1.09%
Revenue beat(4)4
Avg Revenue beat(4)1.48%
Min Revenue beat(4)0.38%
Max Revenue beat(4)2.59%
Revenue beat(8)7
Avg Revenue beat(8)0.55%
Revenue beat(12)9
Avg Revenue beat(12)0.35%
Revenue beat(16)11
Avg Revenue beat(16)0.18%
PT rev (1m)0%
PT rev (3m)-13.71%
EPS NQ rev (1m)-10.67%
EPS NQ rev (3m)-24.76%
EPS NY rev (1m)-7.21%
EPS NY rev (3m)-21.36%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.18%
Valuation
Industry RankSector Rank
PE 11.82
Fwd PE 12.02
P/S 1.15
P/FCF N/A
P/OCF 4.04
P/B 2.28
P/tB N/A
EV/EBITDA 7.89
EPS(TTM)11.1
EY8.46%
EPS(NY)10.91
Fwd EY8.32%
FCF(TTM)-2.77
FCFYN/A
OCF(TTM)32.46
OCFY24.74%
SpS113.69
BVpS57.49
TBVpS-78.58
PEG (NY)N/A
PEG (5Y)0.24
Graham Number119.83
Profitability
Industry RankSector Rank
ROA 0.16%
ROE 1.2%
ROCE 5.55%
ROIC 4.17%
ROICexc 4.19%
ROICexgc 6.38%
OM 19.4%
PM (TTM) 0.61%
GM 59.67%
FCFM N/A
ROA(3y)4.38%
ROA(5y)4.04%
ROE(3y)24.04%
ROE(5y)21%
ROIC(3y)7.69%
ROIC(5y)7%
ROICexc(3y)7.77%
ROICexc(5y)7.07%
ROICexgc(3y)9.25%
ROICexgc(5y)8.36%
ROCE(3y)10.24%
ROCE(5y)9.32%
ROICexgc growth 3Y2.77%
ROICexgc growth 5Y9.04%
ROICexc growth 3Y2.21%
ROICexc growth 5Y7.51%
OM growth 3Y4.56%
OM growth 5Y10.96%
PM growth 3Y-18.21%
PM growth 5Y20%
GM growth 3Y1.25%
GM growth 5Y3.11%
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 4.37
Debt/FCF N/A
Debt/EBITDA 5.22
Cap/Depr 135.06%
Cap/Sales 30.99%
Interest Coverage 2.89
Cash Conversion 67.44%
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z 0.72
F-Score3
WACC9.07%
ROIC/WACC0.46
Cap/Depr(3y)182.39%
Cap/Depr(5y)152.23%
Cap/Sales(3y)41.77%
Cap/Sales(5y)35.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.02%
EPS 3Y19.73%
EPS 5Y48.42%
EPS Q2Q%-28.08%
EPS Next Y-34.22%
EPS Next 2Y-8%
EPS Next 3Y2.01%
EPS Next 5Y12.12%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y19.84%
Revenue growth 5Y12.29%
Sales Q2Q%18.16%
Revenue Next Year25.3%
Revenue Next 2Y19.56%
Revenue Next 3Y15.88%
Revenue Next 5Y14.16%
EBIT growth 1Y7.95%
EBIT growth 3Y25.3%
EBIT growth 5Y24.59%
EBIT Next Year149.71%
EBIT Next 3Y49.34%
EBIT Next 5Y32.27%
FCF growth 1Y76.74%
FCF growth 3Y-46.1%
FCF growth 5YN/A
OCF growth 1Y0.48%
OCF growth 3Y18.08%
OCF growth 5Y14.02%